Clinical trial Recruiting at 1 site Early Phase 1 Interventional Ages 18 and up

Orthobiological Therapies for Musculoskeletal Conditions

Official title: Clinical and Functional Evaluation of Orthobiological Therapies in Musculoskeletal Conditions

Run by Proregen · NCT07434115 · Data updated 2026-11-12

This study tests whether orthobiological treatments like PRP, bone marrow concentrate, hyaluronic acid, and nanofat can help adults with various joint, tendon, cartilage, or bone problems.

More Musculoskeletal Diseases or Conditions trials

Quick facts

PhaseEarly Phase 1
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorProregen
Research network
Locations1 site (Bento Gonçalves, Rio Grande do Sul)
StatusRecruiting
StartedSeptember 16, 2026
Main results expectedJanuary 2029
Study endsJanuary 2030
Registry record updatedSeptember 17, 2026
Trial IDNCT07434115 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older with an eligible musculoskeletal diagnosis who are receiving orthobiological treatment as part of standard care.

Probably not a fit

Patients without meaningful response to orthobiological therapy or with contraindications may see little to no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This early-phase study prospectively records clinical and functional outcomes after orthobiological treatments used in routine care for musculoskeletal conditions. It aims to identify patterns of efficacy by agent type, pathology, and follow-up time, while monitoring safety under defined clinical criteria. Data will come from patients treated at the Proregen Medical Clinic and affiliates, with standardized questionnaires and routine clinical assessments.

Why it matters

Potential benefit: If successful, patients may experience improved pain, function, and quality of life from orthobiological therapies.

How similar studies have gone: Previous work suggests potential benefits for some orthobiologics in musculoskeletal conditions, but evidence remains variable and heterogeneous.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 or older;
* Clinical and/or radiological diagnosis of an eligible musculoskeletal condition;
* Formal clinical indication for treatment with orthobiological agents, according to routine care;
* Regular access to the WhatsApp application, ensuring the necessary communication for sending and receiving digital questionnaires and other study instructions;
* Ability to understand the study and sign the Informed Consent Form.

Exclusion Criteria:

* Medical contraindication to the use of orthobiologics (e.g., active infection, severe hematological diseases, active cancer);
* Recent use (≤3 months) of orthobiologic therapies in the same area to be treated;
* Pregnant or breastfeeding women;
* Cognitive or psychiatric diseases that prevent adequate clinical follow-up;
* Simultaneous participation in another interventional clinical study with the same therapeutic purpose.

Where it's running

  • Clínica Proregen | Clínica Ortopédica em Bento | Dr. André Kruel
    Bento Gonçalves, Rio Grande do Sul, Brazil
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.